Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples

Journal of Clinical Microbiology

Volumn 39, Issue 9, 2001, Pages 3247-3253

  Joyanes, P ^a   Conejo, M D C ^a   Martinez Martinez L ^a   Perea, E J ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; SULTAMICILLIN; TETRACYCLINE; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOANALYZER; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; DIAGNOSTIC TEST; GRAM NEGATIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ACINETOBACTER; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BACTERIOLOGICAL TECHNIQUES; GRAM-NEGATIVE AEROBIC RODS AND COCCI; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; REAGENT KITS, DIAGNOSTIC; STENOTROPHOMONAS;

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS); NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA;

EID: 0034837654     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.9.3247-3253.2001     Document Type: Article

References (25)

1. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing
2. Taxonomy of the genus Acinetobacter with the recognition of Acineto bacter baumannii sp. nov., and Acinetobacter haemolyticus sp. nov., Acinetobacterjohnsonii sp. nov., and Acinetobacter junii sp. nov., and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii
3. Delineation of new proteolytic genomic species in the genus Acinetobacter
4. Imipenem stability in a predried susceptibility panel
5. Lack of additive effect between mechanisms of resistance to carbapenems and other β-lactams in Pseudomonas aeruginosa
6. Multicenter laboratory evaluation of the bio-Merieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa
7. Clinical impact of rapid in vitro susceptibility testing and bacterial identification
8. Susceptibility testing instrumentation and computerized expert systems for data analysis and interpretation
9. Evaluation of the VITEK 2 system for rapid identification of medically relevant gram-negative rods
10. Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime
11. Evaluation of the AutoScan Walkaway system for rapid identification and susceptibility testing of gram-negative bacilli
12. Interplay of impermeability and chromosomal β-lactamase in imipenem-resistant Pseudomonas aeruginosa
13. Multiple antibiotic resistance and efflux
14. False resistance to imipenem with a microdilution susceptibility testing system
15. Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria
16. Ability of the VITEK 2 advanced expert system to identify β-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa
17. Failure of the Vitek AutoMicrobic system to detect beta-lactam resistance in Aeromonas species
18. Automated systems for identification of microorganisms
19. Evalaution of auto-SCAN-W/A automated microbiology system for the identification of non-glucose-fermenting gram-negative bacilli
20. Comparison of the autoSCAN W/A and Vitek Automicrobic systems for identification and susceptibility testing of bacteria
21. Rapid antimicrobial susceptibility testing: Technical and clinical considerations
22. Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels